Abstract
Summary
Poractant Alfa is a natural extract, phospholipids account for 90% of the dry weight, most of which are phosphatidyl choline (PC), the PC with surface activity is phosphatidyl choline dipalmitic acid, the rest of the phospholipids also include phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol and sphingomyelin.In addition, there are two kinds of sp-b and sp-c, which show the active substance (PS) specific proteins.Porcine pneumophylline injection for the treatment and prevention of respiratory distress syndrome (RDS) in premature infants.
LPI (LP Information)' newest research report, the “Poractant Alfa Industry Forecast” looks at past sales and reviews total world Poractant Alfa sales in 2022, providing a comprehensive analysis by region and market sector of projected Poractant Alfa sales for 2023 through 2029. With Poractant Alfa sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Poractant Alfa industry.
This Insight Report provides a comprehensive analysis of the global Poractant Alfa landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Poractant Alfa portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Poractant Alfa market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Poractant Alfa and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Poractant Alfa.
The global Poractant Alfa market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Poractant Alfa is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Poractant Alfa is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Poractant Alfa is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Poractant Alfa players cover Chiesi, Douglas Pharma, Takeda, Mylan and Piramal, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Poractant Alfa market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Rapid Dosing
Microdosing
Segmentation by application
Salvage Treatment
Prevention of Respiratory Distress Syndrome (RDS)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Chiesi
Douglas Pharma
Takeda
Mylan
Piramal
Key Questions Addressed in this Report
What is the 10-year outlook for the global Poractant Alfa market?
What factors are driving Poractant Alfa market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Poractant Alfa market opportunities vary by end market size?
How does Poractant Alfa break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Poractant Alfa Industry Forecast” looks at past sales and reviews total world Poractant Alfa sales in 2022, providing a comprehensive analysis by region and market sector of projected Poractant Alfa sales for 2023 through 2029. With Poractant Alfa sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Poractant Alfa industry.
This Insight Report provides a comprehensive analysis of the global Poractant Alfa landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Poractant Alfa portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Poractant Alfa market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Poractant Alfa and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Poractant Alfa.
The global Poractant Alfa market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Poractant Alfa is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Poractant Alfa is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Poractant Alfa is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Poractant Alfa players cover Chiesi, Douglas Pharma, Takeda, Mylan and Piramal, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Poractant Alfa market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Rapid Dosing
Microdosing
Segmentation by application
Salvage Treatment
Prevention of Respiratory Distress Syndrome (RDS)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Chiesi
Douglas Pharma
Takeda
Mylan
Piramal
Key Questions Addressed in this Report
What is the 10-year outlook for the global Poractant Alfa market?
What factors are driving Poractant Alfa market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Poractant Alfa market opportunities vary by end market size?
How does Poractant Alfa break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Poractant Alfa Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Poractant Alfa by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Poractant Alfa by Country/Region, 2018, 2022 & 2029
2.2 Poractant Alfa Segment by Type
2.2.1 Rapid Dosing
2.2.2 Microdosing
2.3 Poractant Alfa Sales by Type
2.3.1 Global Poractant Alfa Sales Market Share by Type (2018-2023)
2.3.2 Global Poractant Alfa Revenue and Market Share by Type (2018-2023)
2.3.3 Global Poractant Alfa Sale Price by Type (2018-2023)
2.4 Poractant Alfa Segment by Application
2.4.1 Salvage Treatment
2.4.2 Prevention of Respiratory Distress Syndrome (RDS)
2.5 Poractant Alfa Sales by Application
2.5.1 Global Poractant Alfa Sale Market Share by Application (2018-2023)
2.5.2 Global Poractant Alfa Revenue and Market Share by Application (2018-2023)
2.5.3 Global Poractant Alfa Sale Price by Application (2018-2023)
3 Global Poractant Alfa by Company
3.1 Global Poractant Alfa Breakdown Data by Company
3.1.1 Global Poractant Alfa Annual Sales by Company (2018-2023)
3.1.2 Global Poractant Alfa Sales Market Share by Company (2018-2023)
3.2 Global Poractant Alfa Annual Revenue by Company (2018-2023)
3.2.1 Global Poractant Alfa Revenue by Company (2018-2023)
3.2.2 Global Poractant Alfa Revenue Market Share by Company (2018-2023)
3.3 Global Poractant Alfa Sale Price by Company
3.4 Key Manufacturers Poractant Alfa Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Poractant Alfa Product Location Distribution
3.4.2 Players Poractant Alfa Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Poractant Alfa by Geographic Region
4.1 World Historic Poractant Alfa Market Size by Geographic Region (2018-2023)
4.1.1 Global Poractant Alfa Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Poractant Alfa Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Poractant Alfa Market Size by Country/Region (2018-2023)
4.2.1 Global Poractant Alfa Annual Sales by Country/Region (2018-2023)
4.2.2 Global Poractant Alfa Annual Revenue by Country/Region (2018-2023)
4.3 Americas Poractant Alfa Sales Growth
4.4 APAC Poractant Alfa Sales Growth
4.5 Europe Poractant Alfa Sales Growth
4.6 Middle East & Africa Poractant Alfa Sales Growth
5 Americas
5.1 Americas Poractant Alfa Sales by Country
5.1.1 Americas Poractant Alfa Sales by Country (2018-2023)
5.1.2 Americas Poractant Alfa Revenue by Country (2018-2023)
5.2 Americas Poractant Alfa Sales by Type
5.3 Americas Poractant Alfa Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Poractant Alfa Sales by Region
6.1.1 APAC Poractant Alfa Sales by Region (2018-2023)
6.1.2 APAC Poractant Alfa Revenue by Region (2018-2023)
6.2 APAC Poractant Alfa Sales by Type
6.3 APAC Poractant Alfa Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Poractant Alfa by Country
7.1.1 Europe Poractant Alfa Sales by Country (2018-2023)
7.1.2 Europe Poractant Alfa Revenue by Country (2018-2023)
7.2 Europe Poractant Alfa Sales by Type
7.3 Europe Poractant Alfa Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Poractant Alfa by Country
8.1.1 Middle East & Africa Poractant Alfa Sales by Country (2018-2023)
8.1.2 Middle East & Africa Poractant Alfa Revenue by Country (2018-2023)
8.2 Middle East & Africa Poractant Alfa Sales by Type
8.3 Middle East & Africa Poractant Alfa Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Poractant Alfa
10.3 Manufacturing Process Analysis of Poractant Alfa
10.4 Industry Chain Structure of Poractant Alfa
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Poractant Alfa Distributors
11.3 Poractant Alfa Customer
12 World Forecast Review for Poractant Alfa by Geographic Region
12.1 Global Poractant Alfa Market Size Forecast by Region
12.1.1 Global Poractant Alfa Forecast by Region (2024-2029)
12.1.2 Global Poractant Alfa Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Poractant Alfa Forecast by Type
12.7 Global Poractant Alfa Forecast by Application
13 Key Players Analysis
13.1 Chiesi
13.1.1 Chiesi Company Information
13.1.2 Chiesi Poractant Alfa Product Portfolios and Specifications
13.1.3 Chiesi Poractant Alfa Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Chiesi Main Business Overview
13.1.5 Chiesi Latest Developments
13.2 Douglas Pharma
13.2.1 Douglas Pharma Company Information
13.2.2 Douglas Pharma Poractant Alfa Product Portfolios and Specifications
13.2.3 Douglas Pharma Poractant Alfa Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Douglas Pharma Main Business Overview
13.2.5 Douglas Pharma Latest Developments
13.3 Takeda
13.3.1 Takeda Company Information
13.3.2 Takeda Poractant Alfa Product Portfolios and Specifications
13.3.3 Takeda Poractant Alfa Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Takeda Main Business Overview
13.3.5 Takeda Latest Developments
13.4 Mylan
13.4.1 Mylan Company Information
13.4.2 Mylan Poractant Alfa Product Portfolios and Specifications
13.4.3 Mylan Poractant Alfa Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Mylan Main Business Overview
13.4.5 Mylan Latest Developments
13.5 Piramal
13.5.1 Piramal Company Information
13.5.2 Piramal Poractant Alfa Product Portfolios and Specifications
13.5.3 Piramal Poractant Alfa Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Piramal Main Business Overview
13.5.5 Piramal Latest Developments
14 Research Findings and Conclusion